Company Filing History:
Years Active: 1998
Title: Innovations of Mei X Wu in Immunology
Introduction
Mei X Wu is a prominent inventor based in Cambridge, MA, known for her significant contributions to the field of immunology. With a focus on enhancing the understanding of T lymphocyte activation and apoptosis, her work has implications for treating severe immunodeficiency associated with HIV infection.
Latest Patents
Mei X Wu holds a patent titled "Inhibition of APC-mediated apoptosis of activated T lymphocytes." This patent describes methods for interfering with antigen presenting cell-mediated priming of resting peripheral blood T lymphocytes to undergo activation-induced cell death, or apoptosis. The invention involves inhibiting the interaction between a membrane-associated molecule present on stimulated antigen presenting cells and a counter-receptor on T lymphocytes. The methods disclosed are particularly relevant for reducing T lymphocyte depletion associated with HIV infection, thereby mitigating the severe immunodeficiency linked to AIDS.
Career Highlights
Mei X Wu is affiliated with the Dana-Farber Cancer Institute, where she conducts her research and develops innovative solutions in immunology. Her work has garnered attention for its potential to improve therapeutic strategies for patients suffering from HIV-related complications.
Collaborations
One of her notable collaborators is Stuart F Schlossman, with whom she has worked on various research projects aimed at advancing the understanding of immune responses.
Conclusion
Mei X Wu's innovative research and patent contributions are paving the way for new treatments in immunology, particularly in the context of HIV infection. Her work exemplifies the critical role of inventors in advancing medical science and improving patient outcomes.